RecallDepth
Class II Terminated

Cephalexin Capsules, USP, 250 mg, packaged in a) 100-count bottles (NDC 62756-293-88) and b) 500-count bottles (NDC 62756-293-13), Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., Acme Plaza, Andheri-Kurla Road, Andheri (East), Mumbai-400 059, India.

Company
Caraco Pharmaceutical Laboratories, Ltd.
Recall Initiated
June 26, 2014
Posted
August 13, 2014
Recall Number
D-1510-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 70,152 bottles; b) 43,525 bottles
Firm Location
Detroit, MI, United States

Reason for Recall

CGMP Deviations: These products are being recalled because they were manufactured with active pharmaceutical ingredients (APIs) that were not manufactured with good manufacturing practices.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot #: a) AGL0098B, AGL0099B, AGL0100B, AGL0101B, Exp 09/14; AGM0073B, AGM0074B, Exp 04/15; AGM0125B, AGM0126B, Exp 07/15; AGM0158B, Exp 09/15; b) AGL0092A, AGL0093A, AGL0094A, AGL0095A, AGL0096A, AGL0097A, AGL0102A, AGL0103A, AGL0104A, AGL0105A, Exp 09/14; AGM0067A, AGM0068A, AGM0069A, Exp 03/15; AGM0070A, AGM0071A, AGM0072A, AGM0085A, AGM0086A, Exp 04/15; AGM0127A, AGM0128A, AGM0129A, AGM0130A, AGM0131A, AGM0132A, Exp 07/15

More recalls by Caraco Pharmaceutical Laboratories, Ltd.

View all recalls by this company →

Other recent Class II Drug recalls